Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 7 (2010), Issue 9 (September)

1. Germinoma with malignant transformation to nongerminomatous germ cell tumor.
   J Neurosurg Pediatr, 6(3): 295-8. [Abstract] [Full-text]
2. Gliomatosis cerebri: report of 3 cases.
   J Neurosurg Pediatr, 6(3): 291-4. [Abstract] [Full-text]
3. Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance.
   Int J Cancer, 127(9): 2063-75. [Abstract] [Full-text]
4. MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma.
   Int J Cancer, 127(9): 2106-18. [Abstract] [Full-text]
5. Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance.
   Int J Cancer, 127(9): 2063-75. [Abstract] [Full-text]
6. MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma.
   Int J Cancer, 127(9): 2106-18. [Abstract] [Full-text]
7. Long-term health experience of jet engine manufacturing workers: IV. A comparison of central nervous system cancer ascertainment using mortality and incidence data.
   Ann Epidemiol, 20(10): 759-65. [Abstract] [Full-text]
8. Histologically confirmed intracranial germ cell tumors; an analysis of 62 patients in a single institute.
   Virchows Arch, 457(3): 347-57. [Abstract] [Full-text]
9. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
   Cancer Lett, 297(1): 84-90. [Abstract] [Full-text]
10. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
    Cancer Lett, 297(1): 84-90. [Abstract] [Full-text]
11. Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma.
    Br J Cancer, 103(6): 827-36. [Abstract] [Full-text]
12. Incidence of pituitary adenomas in Northern Finland in 1992-2007.
    J Clin Endocrinol Metab, 95(9): 4268-75. [Abstract] [Full-text]
13. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.
    Oncogene, 29(36): 5095-102. [Abstract] [Full-text]
14. Identification and treatment of a pineal region tumor in an adolescent with prodromal psychotic symptoms.
    Am J Psychiatry, 167(9): 1033-7. [Abstract] [Full-text]
15. Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.
    Cancer, 116(18): 4238-47. [Abstract] [Full-text]
16. Isolation, enrichment, and maintenance of medulloblastoma stem cells.
    J Vis Exp. [Abstract] [Full-text]
17. MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.
    Int J Radiat Oncol Biol Phys, 78(2): 572-8. [Abstract] [Full-text]
18. Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Int J Radiat Oncol Biol Phys, 78(2): 398-403. [Abstract] [Full-text]
19. Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 78(2): 605-8. [Abstract] [Full-text]
20. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
    Int J Radiat Oncol Biol Phys, 78(2): 404-8. [Abstract] [Full-text]
21. Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience.
    Int J Radiat Oncol Biol Phys, 78(2): 409-14. [Abstract] [Full-text]
22. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas.
    Int J Radiat Oncol Biol Phys, 78(2): 390-7. [Abstract] [Full-text]
23. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
    Int J Radiat Oncol Biol Phys, 78(2): 385-9. [Abstract] [Full-text]
24. Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.
    Int J Radiat Oncol Biol Phys, 78(2): 379-84. [Abstract] [Full-text]
25. Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH.
    Exp Mol Pathol, 89(2): 169-74. [Abstract] [Full-text]
26. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
    Cancer Res, 70(18): 7283-93. [Abstract] [Full-text]
27. (R,S)-anti-1-amino-2-[18F]fluorocyclopentyl-1-carboxylic acid: synthesis from racemic 2-benzyloxycyclopentanone and biological evaluation for brain tumor imaging with positron emission tomography.
    J Med Chem, 53(18): 6603-7. [Abstract] [Full-text]
28. Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes.
    Eur J Endocrinol, 163(4): 515-22. [Abstract] [Full-text]
29. xCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization.
    Ann Anat, 192(5): 309-13. [Abstract] [Full-text]
30. Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas.
    J Histochem Cytochem, 58(10): 881-9. [Abstract] [Full-text]
31. ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.
    Clin Exp Metastasis, 27(7): 481-91. [Abstract] [Full-text]
32. A pooled analysis of extremely low-frequency magnetic fields and childhood brain tumors.
    Am J Epidemiol, 172(7): 752-61. [Abstract] [Full-text]
33. Olfactory and gustatory hallucinations presenting as partial status epilepticus because of glioblastoma multiforme.
    Ann Emerg Med, 56(4): 374-7. [Abstract] [Full-text]
34. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.
    Cancer, 116(19): 4632-7. [Abstract] [Full-text]
35. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
    Int J Radiat Oncol Biol Phys, 78(3): 849-54. [Abstract] [Full-text]
36. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells.
    Int J Cancer, 127(10): 2300-12. [Abstract] [Full-text]
37. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    Int J Cancer, 127(10): 2478-85. [Abstract] [Full-text]
38. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.
    Int J Cancer, 127(10): 2257-67. [Abstract] [Full-text]
39. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
    Int J Cancer, 127(10): 2313-22. [Abstract] [Full-text]
40. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells.
    Int J Cancer, 127(10): 2300-12. [Abstract] [Full-text]
41. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    Int J Cancer, 127(10): 2478-85. [Abstract] [Full-text]
42. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
    Int J Radiat Oncol Biol Phys, 78(3): 849-54. [Abstract] [Full-text]
43. Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.
    Int J Cancer, 127(10): 2257-67. [Abstract] [Full-text]
44. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
    Int J Cancer, 127(10): 2313-22. [Abstract] [Full-text]
45. Pineal germinoma.
    South Med J, 103(10): 1031-7. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.